ELITE PHARMACEUTICALS INC /NV/·4

Mar 25, 6:13 PM ET

POTTI RAM 4

4 · ELITE PHARMACEUTICALS INC /NV/ · Filed Mar 25, 2013

Insider Transaction Report

Form 4
Period: 2013-03-21
POTTI RAM
Director10% Owner
Transactions
  • Other

    Warrants

    2013-03-256,666,6672,436,665 total(indirect: see footnote)
    Exercise: $0.06From: 2009-06-03Exp: 2016-06-03Common Stock (6,666,667 underlying)
  • Conversion

    Common Stock

    2013-03-21+15,946,50229,027,142 total(indirect: see footnote)
  • Other

    Common Stock

    2013-03-25$0.04/sh13,550,136$500,00015,477,006 total(indirect: see footnote)
  • Conversion

    Series E Convertible Preferred Stock

    2013-03-21$1000.00/sh387.5$387,5001,800 total(indirect: see footnote)
    Exercise: $0.02From: 2013-03-21Common Stock (15,946,502 underlying)
Footnotes (7)
  • [F1]Ram Potti is an equity owner and executive officer of each of Epic Pharma, LLC ("EP"), and Epic Investments, LLC ("EI") (which is controlled by EP), which owns securities convertible into or exercisable for in excess of 10% of the outstanding shares of common stock of the issuer.
  • [F2]Conversion of Series E Preferred Stock of issuer at the rate of approximately 41,152.26 shares of common for each share of such preferred stock.
  • [F3]Of the 29,027,142 shares of common stock, 28,610,803 shares of common stock are owned indirectly through EI and 416,339 shares are owned directly by the reporting person.
  • [F4]Of the 15,477,006 shares of common stock, 15,060,667 shares of common stock are owned indirectly through EI and 416,339 shares are owned directly by the reporting person.
  • [F5]Disposition of shares to its members
  • [F6]Disposition of warrants to its members
  • [F7]N/A

Documents

1 file
  • 4
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT